Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial-Reference-Cited by-同舟云学术

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial

Published:2016-07-08 Issue:3 Volume:21 Page:417-424
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Kimura Genjiro,Kasahara Masato^ORCID,Ueshima Kenji,Tanaka Sachiko,Yasuno Shinji,Fujimoto Akira,Sato Toshiya,Imamoto Miyuki,Kosugi Shinji,Nakao Kazuwa

Funder

Pfizer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/article/10.1007/s10157-016-1304-6/fulltext.html

Reference20 articles.

1. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004;15(11):2816–27.

2. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the treating to new targets (TNT) study. Clin J Am Soc Nephrol. 2007;2(6):1131–9.

3. Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, Tziomalos K, Ganotakis ES, Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transpl. 2007;22(1):118–27.

4. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol. 2006;17(7):2006–16.

5. Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS. Effect of atorvastatin on kidney function in chronic kidney disease: a randomized double-blind placebo-controlled trial. Atherosclerosis. 2010;213(1):218–24.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of Electrolyte Balance and Lipid Profile in Rats Following Oral Administration of Methanolic Fruit Pulp Extract of Azanza garckeana (Tula Kola Nut);2024-06-19

2. Statin use and in-hospital outcomes among chronic kidney disease patients: a retrospective cohort study;2024-03-21

3. Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional Study;Journal of Atherosclerosis and Thrombosis;2024

4. CD36-mediated podocyte lipotoxicity promotes foot process effacement;Open Medicine;2024-01-01

5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29